Published in J Gastrointest Surg on January 19, 2011
Cisplatin resistance: a cellular self-defense mechanism resulting from multiple epigenetic and genetic changes. Pharmacol Rev (2012) 2.31
miR-148a promoted cell proliferation by targeting p27 in gastric cancer cells. Int J Biol Sci (2011) 1.33
The clinical significance of MiR-148a as a predictive biomarker in patients with advanced colorectal cancer. PLoS One (2012) 1.26
MicroRNA-148a promotes myogenic differentiation by targeting the ROCK1 gene. J Biol Chem (2012) 1.20
The role of microRNAs in cancers of the upper gastrointestinal tract. Nat Rev Gastroenterol Hepatol (2012) 1.17
MicroRNA involvement in esophageal carcinogenesis. Curr Opin Pharmacol (2011) 0.95
Pharmaco-miR: linking microRNAs and drug effects. Brief Bioinform (2013) 0.92
microRNA-106a modulates cisplatin sensitivity by targeting PDCD4 in human ovarian cancer cells. Oncol Lett (2013) 0.91
MicroRNA signatures in chemotherapy resistant esophageal cancer cell lines. World J Gastroenterol (2014) 0.89
The rescue of miR-148a expression in pancreatic cancer: an inappropriate therapeutic tool. PLoS One (2013) 0.89
Proton pump inhibitors (PPIs) impact on tumour cell survival, metastatic potential and chemotherapy resistance, and affect expression of resistance-relevant miRNAs in esophageal cancer. J Exp Clin Cancer Res (2014) 0.87
miR-148b reverses cisplatin-resistance in non-small cell cancer cells via negatively regulating DNA (cytosine-5)-methyltransferase 1(DNMT1) expression. J Transl Med (2015) 0.87
MicroRNAs: promising chemoresistance biomarkers in gastric cancer with diagnostic and therapeutic potential. World J Gastroenterol (2014) 0.87
MicroRNA-148a reduces tumorigenesis and increases TRAIL-induced apoptosis in NSCLC. Proc Natl Acad Sci U S A (2015) 0.87
The Role of Mir-148a in Cancer. J Cancer (2016) 0.80
Specific Roles of MicroRNAs in Their Interactions with Environmental Factors. J Nucleic Acids (2012) 0.80
Predicting the Response of Neoadjuvant Therapy for Patients with Esophageal Carcinoma: an In-depth Literature Review. J Cancer (2015) 0.76
RKNNMDA: Ranking-based KNN for MiRNA-Disease Association prediction. RNA Biol (2017) 0.76
MiR-218 increases sensitivity to cisplatin in esophageal cancer cells via targeting survivin expression. Open Med (Wars) (2016) 0.75
MiR-148a modulates HLA-G expression and influences tumor apoptosis in esophageal squamous cell carcinoma. Exp Ther Med (2017) 0.75
MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types. Eur J Cancer (2009) 2.56
Results of laparoscopic antireflux operations in patients who have Barrett's esophagus. Chest Surg Clin N Am (2002) 1.95
Hypoxic enhancement of exosome release by breast cancer cells. BMC Cancer (2012) 1.92
High-risk human papillomavirus in esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev (2010) 1.83
An evaluation of prognostic factors and tumor staging of resected carcinoma of the esophagus. Ann Surg (2007) 1.79
Improving surveillance for Barrett's oesophagus. BMJ (2006) 1.60
Prospective randomized controlled trial of argon plasma coagulation ablation vs. endoscopic surveillance of patients with Barrett's esophagus after antireflux surgery. Gastrointest Endosc (2004) 1.56
EP300--a miRNA-regulated metastasis suppressor gene in ductal adenocarcinomas of the pancreas. Int J Cancer (2010) 1.51
Genome-wide copy number analysis in esophageal adenocarcinoma using high-density single-nucleotide polymorphism arrays. Cancer Res (2008) 1.50
Circulating microRNA expression is reduced in chronic kidney disease. Nephrol Dial Transplant (2011) 1.50
Five-year follow-up of a multicenter, double-blind randomized clinical trial of laparoscopic Nissen vs anterior 90 degrees partial fundoplication. Arch Surg (2010) 1.48
The VHL-dependent regulation of microRNAs in renal cancer. BMC Med (2010) 1.46
Prox1 expression is negatively regulated by miR-181 in endothelial cells. Blood (2010) 1.45
Recurrent symptoms after fundoplication with a negative pH study--recurrent reflux or functional heartburn? J Gastrointest Surg (2008) 1.44
Objective outcomes 14 years after laparoscopic anterior 180-degree partial versus nissen fundoplication: results from a randomized trial. Ann Surg (2013) 1.44
Laparoscopic anterior 90 degree fundoplication for reflux or large hiatus hernia. ANZ J Surg (2008) 1.43
Galanin mediates the pathogenesis of cerulein-induced acute pancreatitis in the mouse. Pancreas (2010) 1.43
Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas. Ann Surg Oncol (2009) 1.38
Laparoscopic placement of peritoneal dialysis catheters: 7 years experience. ANZ J Surg (2003) 1.32
Minimally invasive versus open esophagectomy for patients with esophageal cancer. Ann Thorac Surg (2009) 1.30
Global analysis of the mammalian RNA degradome reveals widespread miRNA-dependent and miRNA-independent endonucleolytic cleavage. Nucleic Acids Res (2011) 1.24
Factors associated with postoperative pulmonary morbidity after esophagectomy for cancer. Ann Surg Oncol (2010) 1.24
Review: The role of microRNAs in kidney disease. Nephrology (Carlton) (2010) 1.22
Influence of follow-up methodology and completeness on apparent clinical outcome of fundoplication. Am J Surg (2003) 1.18
Human gastrointestinal neoplasia-associated myofibroblasts can develop from bone marrow-derived cells following allogeneic stem cell transplantation. Stem Cells (2009) 1.14
The influence of prediagnostic demographic and lifestyle factors on esophageal squamous cell carcinoma survival. Int J Cancer (2012) 1.13
A core erythroid transcriptional network is repressed by a master regulator of myelo-lymphoid differentiation. Proc Natl Acad Sci U S A (2012) 1.12
Improving the accuracy of TNM staging in esophageal cancer: a pathological review of resected specimens. Ann Surg Oncol (2008) 1.12
Randomized trial of division versus nondivision of the short gastric vessels during laparoscopic Nissen fundoplication: 10-year outcomes. Ann Surg (2008) 1.10
Transoral incisionless fundoplication 2.0 procedure using EsophyX™ for gastroesophageal reflux disease. J Gastrointest Surg (2010) 1.08
Division of short gastric vessels at laparoscopic nissen fundoplication: a prospective double-blind randomized trial with 5-year follow-up. Ann Surg (2002) 1.07
Chemotherapy-induced modification of microRNA expression in esophageal cancer. Oncol Rep (2011) 1.07
The tumor cell-host organ interface in the early onset of metastatic organ colonisation. Clin Exp Metastasis (2007) 1.04
CPSP-web-tools: a server for 3D lattice protein studies. Bioinformatics (2009) 1.03
Metallothionien 3 expression is frequently down-regulated in oesophageal squamous cell carcinoma by DNA methylation. Mol Cancer (2005) 1.03
Oscillations by minimal bacterial suicide circuits reveal hidden facets of host-circuit physiology. PLoS One (2010) 1.02
Histone deacetylase inhibition in colorectal cancer cells reveals competing roles for members of the oncogenic miR-17-92 cluster. Mol Carcinog (2012) 1.00
Laparoscopic Nissen fundoplication: clinical outcomes at 10 years. J Am Coll Surg (2007) 1.00
Endo-vacuum assisted closure treatment for rectal anastomotic insufficiency. Dis Colon Rectum (2008) 0.99
MicroRNAs and esophageal cancer--implications for pathogenesis and therapy. Curr Pharm Des (2013) 0.97
Current status and future perspective of general surgical trainees in the Netherlands. World J Surg (2007) 0.97
Barrett's esophagus. J Gastroenterol Hepatol (2011) 0.97
Is endoscopic surveillance for non-dysplastic Barrett's esophagus cost-effective? Review of economic evaluations. J Gastroenterol Hepatol (2011) 0.96
Laparoscopic anterior 180-degree versus nissen fundoplication for gastroesophageal reflux disease: systematic review and meta-analysis of randomized clinical trials. Ann Surg (2013) 0.96
Acute ruptured esophageal duplication cyst. Dis Esophagus (2004) 0.95
Predictors of survival among patients diagnosed with adenocarcinoma of the esophagus and gastroesophageal junction. Cancer Causes Control (2012) 0.95
Sensitive quantitative analysis of murine LINE1 DNA methylation using high resolution melt analysis. Epigenetics (2012) 0.95
MicroRNAs, development of Barrett's esophagus, and progression to esophageal adenocarcinoma. World J Gastroenterol (2010) 0.95
Outcome of oesophagectomy for adenocarcinoma of the oesophagus and oesophagogastric junction. ANZ J Surg (2005) 0.94
Whole genome expression array profiling highlights differences in mucosal defense genes in Barrett's esophagus and esophageal adenocarcinoma. PLoS One (2011) 0.94
MicroRNA-143 and -205 expression in neosquamous esophageal epithelium following Argon plasma ablation of Barrett's esophagus. J Gastrointest Surg (2009) 0.92
In vivo tumor cell adhesion in the pulmonary microvasculature is exclusively mediated by tumor cell--endothelial cell interaction. BMC Cancer (2010) 0.92
DNA methylation of the ABO promoter underlies loss of ABO allelic expression in a significant proportion of leukemic patients. PLoS One (2009) 0.91
Australian clinical practice guidelines for the diagnosis and management of Barrett's esophagus and early esophageal adenocarcinoma. J Gastroenterol Hepatol (2015) 0.91
Preoperative prediction of long-term outcome following laparoscopic fundoplication. ANZ J Surg (2002) 0.90
Five-year outcome after laparoscopic anterior partial versus Nissen fundoplication: four randomized trials. Ann Surg (2012) 0.90
Fungal virulence in a lepidopteran model is an emergent property with deterministic features. MBio (2013) 0.90
SERPINB5 and AKAP12 - expression and promoter methylation of metastasis suppressor genes in pancreatic ductal adenocarcinoma. BMC Cancer (2010) 0.90
Disease-enhancing antibodies improve the efficacy of bacterial toxin-neutralizing antibodies. Cell Host Microbe (2013) 0.90
Investigation of serotonin type 4 receptor expression in human and non-human primate gastrointestinal samples. Eur J Gastroenterol Hepatol (2006) 0.89
Prognostic impact of underlying liver fibrosis and cirrhosis after curative resection of hepatocellular carcinoma. World J Surg (2010) 0.89
The effect of obesity on the outcome of laparoscopic antireflux surgery. J Gastrointest Surg (2009) 0.88
Impact of gastro-esophageal reflux on mucin mRNA expression in the esophageal mucosa. J Gastrointest Surg (2008) 0.88
miR-200 family expression is downregulated upon neoplastic progression of Barrett's esophagus. World J Gastroenterol (2011) 0.88
Effect of sex on symptoms associated with gastroesophageal reflux. Arch Surg (2011) 0.88
Analyzing miRNAs in ductal adenocarcinomas of the pancreas. J Surg Res (2009) 0.87
Impact of gender and age on the long-term outcome of laparoscopic fundoplication. World J Surg (2009) 0.87
MicroRNAs in brain tumors : a new diagnostic and therapeutic perspective? Mol Neurobiol (2011) 0.87
Blended learning in surgery using the Inmedea Simulator. Langenbecks Arch Surg (2012) 0.87
Endoscopic stapling for pharyngeal pouch: does it make the cut? ANZ J Surg (2004) 0.87
Differential expression of microRNA-1 in dorsal root ganglion neurons. Histochem Cell Biol (2010) 0.86
Epigenetic markers for chemosensitivity and chemoresistance in pancreatic cancer--a review. Int J Cancer (2011) 0.86
Preoperative factors predicting clinical outcome following laparoscopic fundoplication. World J Surg (2014) 0.85
MiRNAs and their association with locoregional staging and survival following surgery for esophageal carcinoma. Ann Surg Oncol (2010) 0.85
Laparoscopic antireflux surgery in the elderly. Surg Endosc (2007) 0.85
Producing high-accuracy lattice models from protein atomic coordinates including side chains. Adv Bioinformatics (2012) 0.85
Early reoperation after laparoscopic fundoplication: the importance of routine postoperative contrast studies. World J Surg (2010) 0.85
Metastatic tumor cell arrest in the liver-lumen occlusion and specific adhesion are not exclusive. Int J Colorectal Dis (2009) 0.85
High frequency of systemic mycoplasmal infections in Gulf War veterans and civilians with Amyotrophic Lateral Sclerosis (ALS). J Clin Neurosci (2002) 0.85
Quality of life following laparoscopic anterior 90 degrees versus Nissen fundoplication: results from a multicenter randomized trial. World J Surg (2006) 0.85
Circulating Serum Exosomal miRNAs As Potential Biomarkers for Esophageal Adenocarcinoma. J Gastrointest Surg (2015) 0.84
Estrogen, male dominance and esophageal adenocarcinoma: is there a link? World J Gastroenterol (2012) 0.84
Laparoscopic cardiomyotomy for achalasia: long-term outcomes. ANZ J Surg (2006) 0.84